NCT02065167View on ClinicalTrials.gov

Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

December 31, 2017

Conditions
Avascular Necrosis of the Femoral Head
Interventions
BIOLOGICAL

Cultured autologous Mesenchymal Cells

Cultured Mesenchymal Cells from bone marrow isolation, expanded under GMP protocol in associated facilities and introduced at the end of the appropriate forage up to the femoral head under fluoroscopic control.

Trial Locations (6)

28046

"Servicio de Cirugía Ortopédica y Traumatología A, Hospital La Paz", Madrid

37044

Department of Orthopaedic Surgery, CHU Tours, Tours

40136

Istituto Ortopedico Rizzoli, Bologna

72076

University Children's Hospital, Tübingen

94000

Department of Orthopaedic Surgery, Hôpital Henri Mondor, Créteil

8907581

Department of Orthopaedic Trauma, University of Ulm, Ulm

All Listed Sponsors
lead

Universidad Autonoma de Madrid

OTHER

NCT02065167 - Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip | Biotech Hunter | Biotech Hunter